fluoxetine has been researched along with levodopa in 31 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (9.68) | 18.7374 |
1990's | 10 (32.26) | 18.2507 |
2000's | 6 (19.35) | 29.6817 |
2010's | 12 (38.71) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Jones, GT; Moore, RA; Slater, IH | 1 |
Jansen, EN; Kölling, P | 1 |
Jackson, DM; Jenkins, OF | 1 |
Jones, RS | 1 |
Agid, Y; Blin, J; Bonnet, AM; Durif, F; Vidailhet, M | 1 |
Blin, O; Fabre, N; Montastruc, JL; Rascol, A; Rascol, O; Senard, JM | 1 |
Huszonek, JJ | 1 |
Lauterbach, EC | 1 |
Hesselink, JM | 1 |
Cherin, P; Colvez, A; Deville de Periere, G; Sereni, D | 1 |
Almeida, OP; Tamai, S | 1 |
Allikmets, L; Matto, V; Skrebuhhova, T | 1 |
Bhatia, KP; Marsden, CD; Mathen, D | 1 |
Kannari, K; Matsunaga, M; Shen, H; Suda, T; Yamato, H | 1 |
Bilbao Garay, J; Castilla Castellano, V; Dhimes Tejada, P; Mesa Plaza, N | 1 |
Bagheri, H; Montastruc, JL; Schmitt, L | 1 |
Araujo Silva, MT; Barbosa, ER; Bermpohl, F; Boggio, PS; Fregni, F; Mansur, CG; Marcolin, MA; Odebrecht Rosa, M; Pascual-Leone, A; Rigonatti, SP; Rosa, M; Rumi, DO | 1 |
Arai, A; Baba, M; Kannari, K; Shen, H; Tomiyama, M | 1 |
Linazasoro, G; Van Blercom, N | 1 |
Ansorge, MS; Esposito, E; Gingrich, JA; Gray, N; Moore, H; Morelli, E; Rebello, TJ; Steele, K | 1 |
Abe, M; Inden, M; Kitamura, Y; Minamino, H; Takata, K; Tooyama, I; Yoshimoto, K | 1 |
Bishop, C; Buchta, W; Dickinson, SO; Eissa, S; Eskow Jaunarajs, KL; George, JA; Goldenberg, AA; Mohamed, M | 1 |
Berrocoso, E; Mico, JA; Miguelez, C; Ugedo, L | 1 |
Af Bjerkén, S; Gerhardt, GA; Nevalainen, N; Strömberg, I | 1 |
Fitzgerald, PJ; Maren, S; Seemann, JR | 1 |
Gore, C; Wu, C | 1 |
4 review(s) available for fluoxetine and levodopa
Article | Year |
---|---|
[Serotonin syndrome: report of a fatal case and review of the literature].
Topics: Aged; Antiparkinson Agents; Carbidopa; Depressive Disorder, Major; Drug Combinations; Drug Synergism; Fatal Outcome; Fluoxetine; Humans; Levodopa; Male; Parkinson Disease; Selective Serotonin Reuptake Inhibitors; Selegiline; Serotonin Syndrome | 2002 |
[Pathological gambling behavior in a patient with Parkinson's disease treated with levodopa and bromocriptine].
Topics: Antidepressive Agents; Antiparkinson Agents; Bromocriptine; Citalopram; Depressive Disorder; Dopamine Agents; Female; Fluoxetine; Gambling; Humans; Levodopa; Middle Aged; Parkinson Disease | 2003 |
Can fear extinction be enhanced? A review of pharmacological and behavioral findings.
Topics: Animals; Conditioning, Classical; Extinction, Psychological; Fear; Fluoxetine; Humans; Levodopa; Neurotransmitter Agents; Propranolol; Yohimbine | 2014 |
Medical Therapies of Amblyopia: Translational Research to Expand Our Treatment Armamentarium.
Topics: Amblyopia; Carbidopa; Cholinesterase Inhibitors; Donepezil; Dopamine Agonists; Drug Combinations; Fluoxetine; Humans; Indans; Levodopa; Neuronal Plasticity; Piperidines; Selective Serotonin Reuptake Inhibitors; Translational Research, Biomedical; Visual Cortex | 2016 |
2 trial(s) available for fluoxetine and levodopa
Article | Year |
---|---|
Does fluoxetine aggravate Parkinson's disease? A pilot prospective study.
Topics: Aged; Drug Therapy, Combination; Female; Fluoxetine; Humans; Levodopa; Male; Neurologic Examination; Parkinson Disease; Parkinson Disease, Secondary; Pilot Projects; Prospective Studies; Treatment Outcome | 1995 |
Effect of repetitive TMS and fluoxetine on cognitive function in patients with Parkinson's disease and concurrent depression.
Topics: Aged; Antiparkinson Agents; Cognition Disorders; Depressive Disorder, Major; Double-Blind Method; Female; Fluoxetine; Functional Laterality; Humans; Levodopa; Male; Neuropsychological Tests; Parkinson Disease; Periodicity; Prefrontal Cortex; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Transcranial Magnetic Stimulation | 2005 |
25 other study(ies) available for fluoxetine and levodopa
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Depression of REM sleep in cats by nisoxetine, a potential antidepressant drug.
Topics: Animals; Cats; Depression, Chemical; Drug Interactions; Fluoxetine; Levodopa; Male; Nortriptyline; Phenyl Ethers; Propylamines; Serotonin; Sleep, REM; Time Factors | 1976 |
[Parkinsonism following addition of fluoxetine to treatment with neuroleptics or carbamazepine].
Topics: Depression; Female; Fluoxetine; Humans; Levodopa; Middle Aged; Parkinson Disease; Parkinson Disease, Secondary | 1992 |
Bromocriptine potentiates the behavioural effects of directly and indirectly acting dopamine receptor agonists in mice.
Topics: alpha-Methyltyrosine; Animals; Bromocriptine; Desipramine; Drug Synergism; Fluoxetine; Haloperidol; Levodopa; Male; Methyltyrosines; Mice; Motor Activity; Nomifensine; Receptors, Dopamine; Reserpine | 1985 |
In vivo pharmacological studies on the interactions between tryptamine and 5-hydroxytryptamine.
Topics: 5-Hydroxytryptophan; Animals; Behavior, Animal; Chickens; Deglutition; Female; Fluoxetine; Levodopa; Male; Mice; p-Chloroamphetamine; Rats; Serotonin; Tranylcypromine; Tryptamines | 1981 |
Levodopa-induced dyskinesias are improved by fluoxetine.
Topics: Antiparkinson Agents; Apomorphine; Dyskinesia, Drug-Induced; Fluoxetine; Humans; Levodopa; Middle Aged | 1995 |
Anticholinergic effects in a depressed parkinsonian patient.
Topics: Aged; Benztropine; Carbidopa; Depressive Disorder; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fluoxetine; Humans; Levodopa; Male; Parkinson Disease; Treatment Outcome | 1995 |
Dopaminergic hallucinosis with fluoxetine in Parkinson's disease.
Topics: Aged; Bromocriptine; Carbidopa; Fluoxetine; Hallucinations; Humans; Levodopa; Male; Parkinson Disease; Visual Perception | 1993 |
Serotonin and Parkinson's disease.
Topics: Basal Ganglia Diseases; Depressive Disorder; Dopamine; Drug Therapy, Combination; Fluoxetine; Humans; Levodopa; Parkinson Disease; Serotonin; Tryptophan | 1993 |
Risk of syncope in the elderly and consumption of drugs: a case-control study.
Topics: Acepromazine; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Antiparkinson Agents; Antipsychotic Agents; Case-Control Studies; Drug Utilization; Drug-Related Side Effects and Adverse Reactions; Female; Fluoxetine; Haloperidol; Humans; Levodopa; Male; Matched-Pair Analysis; Pharmacoepidemiology; Risk; Syncope | 1997 |
Nortriptyline for the treatment of depression in progressive supranuclear palsy.
Topics: Adrenergic Uptake Inhibitors; Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Depression; Dopamine Agents; Female; Fluoxetine; Humans; Levodopa; Nortriptyline; Remission Induction; Supranuclear Palsy, Progressive | 1997 |
The effect of antidepressants on rat aggressive behavior in the electric footshock and apomorphine-induced aggressiveness paradigms.
Topics: Aggression; Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Apomorphine; Citalopram; Desipramine; Dopamine Agents; Electroshock; Fluoxetine; Levodopa; Male; Pain Measurement; Rats; Rats, Wistar; Tryptophan | 1998 |
SSRI-induced reversal of levodopa benefit in two patients with dopa-responsive dystonia.
Topics: Adult; Antiparkinson Agents; Dystonia; Female; Fluoxetine; Humans; Levodopa; Recurrence; Selective Serotonin Reuptake Inhibitors; Stress, Psychological | 1999 |
Fluoxetine reduces L-DOPA-derived extracellular DA in the 6-OHDA-lesioned rat striatum.
Topics: Adrenergic Agents; Animals; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Dopamine Agents; Extracellular Space; Fluoxetine; Levodopa; Male; Parkinson Disease; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors | 2001 |
Reuptake of L-DOPA-derived extracellular dopamine in the striatum with dopaminergic denervation via serotonin transporters.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Drug Interactions; Extracellular Fluid; Fluoxetine; Homovanillic Acid; Levodopa; Male; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins | 2006 |
Severe stuttering and motor tics responsive to cocaine.
Topics: Adult; Cocaine; Dopamine Agonists; Fluoxetine; Humans; Levodopa; Male; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Stuttering; Tics | 2007 |
Chronic 5-HT transporter blockade reduces DA signaling to elicit basal ganglia dysfunction.
Topics: 3,4-Dihydroxyphenylacetic Acid; Age Factors; Animals; Animals, Newborn; Basal Ganglia; Cell Count; Chromatography, High Pressure Liquid; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Exploratory Behavior; Fluoxetine; Homovanillic Acid; Levodopa; Male; Mice; Mice, Transgenic; Movement Disorders; Psychomotor Performance; Random Allocation; Rotarod Performance Test; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Signal Transduction; Substantia Nigra; Ventral Tegmental Area | 2011 |
Effect of selective serotonin reuptake inhibitors via 5-HT1A receptors on L-DOPA-induced rotational behavior in a hemiparkinsonian rat model.
Topics: Animals; Behavior, Animal; Corpus Striatum; Dopaminergic Neurons; Fluoxetine; Histones; Levodopa; Male; MAP Kinase Signaling System; Oxidopamine; Parkinson Disease; Phosphorylation; Piperazines; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1A; Selective Serotonin Reuptake Inhibitors; Serotonergic Neurons; Serotonin; Serotonin 5-HT1 Receptor Antagonists; Substantia Nigra; Tyrosine 3-Monooxygenase | 2012 |
Serotonin transporter inhibition attenuates l-DOPA-induced dyskinesia without compromising l-DOPA efficacy in hemi-parkinsonian rats.
Topics: Animals; Antiparkinson Agents; Apomorphine; Biogenic Monoamines; Citalopram; Corpus Striatum; Dyskinesia, Drug-Induced; Fluoxetine; Levodopa; Male; Parkinsonian Disorders; Paroxetine; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors | 2012 |
L-DOPA modifies the antidepressant-like effects of reboxetine and fluoxetine in rats.
Topics: Animals; Antidepressive Agents; Contraindications; Depression; Drug Therapy, Combination; Fluoxetine; Levodopa; Locus Coeruleus; Male; Morpholines; Motor Activity; Rats; Rats, Sprague-Dawley; Reboxetine; Treatment Outcome | 2013 |
Serotonergic nerve fibers in L-DOPA-derived dopamine release and dyskinesia.
Topics: Animals; Corpus Striatum; Dopamine; Dyskinesia, Drug-Induced; Female; Fluoxetine; Levodopa; Nerve Fibers; Rats; Rats, Sprague-Dawley; Serotonergic Neurons; Serotonin Plasma Membrane Transport Proteins | 2014 |